Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Bioactive Compounds

Bioactive Compounds

Items 11171-11180 of 12129

Page
per page
  1. Fluvastatin Sodium
    A4363 Fluvastatin Sodium
    Summary: HMG-CoA reductase inhibitor
  2. Safinamide Mesylate
    A4368 Safinamide Mesylate
    Summary: MAO-B inhibitor,potent,selective and reversible
  3. Dalcetrapib (JTT-705, RO4607381)
    A4376 Dalcetrapib (JTT-705, RO4607381)
    Summary: rhCETP inhibitor
      insoluble in H2O; ≥12.7 mg/mL
  4. Lonafarnib
    A4379 Lonafarnib
    Target: FPTase
    Summary: Ftase inhibitor,potent and selective
      ≥31.95 mg/mL
  5. 7-Methoxycoumarin-4-acetyl-P-L-G-L-β-(2,4-dinitrophenylamino)A-R amide
    A1500 7-Methoxycoumarin-4-acetyl-P-L-G-L-β-(2,4-dinitrophenylamino)A-R amide
    Summary: Substrate of matrix metalloproteinases assay
      ≥48.7 mg/mL
      insoluble in H2O
  6. CA 074
    A1926 CA 074
     2 Citation
    Target: Cathepsins
    Summary: Cathepsin B inhibitor
      ≥19.17 mg/mL
  7. HBcAg [Hepatitis B virus] (18-27)
    A1140 HBcAg [Hepatitis B virus] (18-27)
    Summary: Indicator of active viral replication
      ≥115.5 mg/mL
  8. Carfilzomib (PR-171)
    A1933 Carfilzomib (PR-171)
     10 Citation
    Target: Proteasome
    Summary: Proteasome inhibitor, epoxomicin analog
      ≥35.99 mg/mL
  9. Cyclo (-RGDfK)
    A8164 Cyclo (-RGDfK)
     6 Citation
    Summary: Inhibitor of αvβ3 integrin
      ≥30.19 mg/mL
  10. (E)-2-Decenoic acid
    A3104 (E)-2-Decenoic acid
    Summary: Fatty acid identified in royal jelly

Items 11171-11180 of 12129

Page
per page